As of 2025-08-13, the Intrinsic Value of Cogent Biosciences Inc (COGT) is -7.90 USD. This COGT valuation is based on the model Peter Lynch Fair Value. With the current market price of 11.55 USD, the upside of Cogent Biosciences Inc is -168.36%.
Based on its market price of 11.55 USD and our intrinsic valuation, Cogent Biosciences Inc (COGT) is overvalued by 168.36%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.90 - -7.90 | -7.90 | -168.36% |
| P/E | (37.74) - (59.44) | (42.72) | -469.8% |
| DDM - Stable | (13.10) - (51.73) | (32.41) | -380.6% |
| DDM - Multi | (0.19) - (0.58) | (0.29) | -102.5% |
| Market Cap (mil) | 1,971.42 |
| Beta | 1.32 |
| Outstanding shares (mil) | 170.69 |
| Enterprise Value (mil) | 1,971.42 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.59% |
| Cost of Debt | 5.00% |
| WACC | 6.63% |